论文部分内容阅读
目的观察探讨胺碘酮治疗快速室上性心律失常的临床疗效,总结其临床应用价值。方法选取我院2009年3月至2011年3月42例发作至就诊的时间在48 h内的急诊室上性心律失常的患者,随机分为观察组和对照组,各21例,观察组采用胺碘酮治疗,对照组采用心律平治疗,观察比较两者疗效及不良反应。结果两组治疗效果比较存在一定差异(P<0.05),具有统计学意义。观察组治疗后共发生不良反应2例,发生率为9.6%,对照组共发生不良反应6例,发生率为28.6%,两组不良反应比较差异显著(P<0.05),具有统计学意义。结论胺碘酮治疗快速室上性心律失常的临床疗效明显,能迅速缓解患者的临床症状,药物不良反应少,安全可靠,具有重要的临床应用价值。
Objective To investigate the clinical efficacy of amiodarone in the treatment of rapid supraventricular arrhythmias and to summarize its clinical value. Methods From March 2009 to March 2011, 42 cases of emergency room upper arrhythmia within 48 hours from onset to treatment were randomly divided into observation group and control group, 21 cases in each group. The observation group was adopted Amiodarone treatment, the control group with heart rate treatment, observation and comparison of both efficacy and adverse reactions. Results There was a significant difference between the two groups in the treatment effect (P <0.05), with statistical significance. There were 2 adverse reactions in the observation group after treatment, the incidence rate was 9.6%. There were 6 adverse reactions in the control group, the incidence rate was 28.6%. There was significant difference between the two groups (P <0.05). Conclusions Amiodarone is effective in treating supraventricular tachyarrhythmia. It can relieve the clinical symptoms, reduce the side effects and reduce the side effects of amiodarone. It has important clinical value.